DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
AXRX logo

Amexdrug Corporation Stock Price

OTCPK:AXRX Community·US$33.8k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

AXRX Share Price Performance

US$0.0002
0.00 (0.00%)
​
US$0.0002
0.00 (0.00%)
​
Price US$0.0002
Fri, 11 Sep 26
Share Pricen/a

AXRX Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight risk with weak fundamentals.

4 Risks
0 Rewards
View Full Analysis

Amexdrug Corporation Key Details

US$9.2m

Revenue

US$7.9m

Cost of Revenue

US$1.3m

Gross Profit

US$1.1m

Other Expenses

US$165.8k

Earnings

Last Reported Earnings
Jun 30, 2013
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About AXRX

Founded
1963
Employees
n/a
CEO
Jack Amin
WebsiteView website
www.amexdrug.com

Amexdrug Corporation, through its subsidiaries, engages in the research, development, manufacturing, and distribution of pharmaceutical drugs in the United States. The company operates in two segments, Distribution, and Health and Beauty Products. It offers brand and generic pharmaceuticals, prescription and over-the-counter drugs, non-drug products, health and beauty products, nutritional supplements, as well as pharmacy and laboratory supplies under the Sponix brand name. The company is also involved in private manufacturing and labeling activities. It sells its products through traditional wholesale distribution lines, e-commerce venues, and owned website to independent pharmacies, secondarily to small-sized pharmacy chains, and alternative care facilities, as well as wholesalers and retailers. The company was formerly known as Harlyn Products, Inc. and changed its name to Amexdrug Corporation in April 2000. Amexdrug Corporation was incorporated in 1963 and is based in Commerce, California.

Recent AXRX News & Updates

No updates

Recent updates

No updates

Amexdrug Corporation Competitors

GLBH logo

Globaltech Holdings

Symbol: OTCPK:GLBH
Market cap: US$54.2k
VRSE.F logo

Verisante Technology

Symbol: OTCPK:VRSE.F
Market cap: US$52.7k
SOFE logo

SOAFEE

Symbol: OTCPK:SOFE
Market cap: US$50.7k
OMWS logo

Omnia Wellness

Symbol: OTCPK:OMWS
Market cap: US$46.8k
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide